These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20980474)
1. The welcome resurgence of the α-cell: a pro glucagon commentary. Robertson RP Diabetes; 2010 Nov; 59(11):2735-6. PubMed ID: 20980474 [No Abstract] [Full Text] [Related]
2. [Pax4 transdifferentiates glucagon-secreting alpha cells to insulin-secreting beta endocrine pancreatic cells]. Collombat P; Mansouri A Med Sci (Paris); 2009; 25(8-9):763-5. PubMed ID: 19765395 [No Abstract] [Full Text] [Related]
4. Interaction of islet α-cell and β-cell in the regulation of glucose homeostasis in HI/HA syndrome patients with the GDH(H454Y) mutation. Jia G; Sowers JR Diabetes; 2014 Dec; 63(12):4008-10. PubMed ID: 25414017 [No Abstract] [Full Text] [Related]
5. Circadian orchestration of insulin and glucagon release. Petrenko V; Dibner C Cell Cycle; 2017 Jun; 16(12):1141-1142. PubMed ID: 28537528 [No Abstract] [Full Text] [Related]
6. Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxins. Green AD; Vasu S; Moffett RC; Flatt PR Biochimie; 2016 Jun; 125():119-25. PubMed ID: 27015674 [TBL] [Abstract][Full Text] [Related]
7. Reduction of plasma membrane glutamate transport potentiates insulin but not glucagon secretion in pancreatic islet cells. Feldmann N; del Rio RM; Gjinovci A; Tamarit-Rodriguez J; Wollheim CB; Wiederkehr A Mol Cell Endocrinol; 2011 May; 338(1-2):46-57. PubMed ID: 21371522 [TBL] [Abstract][Full Text] [Related]
8. Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets. Reissaus CA; Piston DW Diabetes; 2017 Apr; 66(4):960-969. PubMed ID: 28130310 [TBL] [Abstract][Full Text] [Related]
9. The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets. Kelly C; Parke HG; McCluskey JT; Flatt PR; McClenaghan NH Diabetes Metab Res Rev; 2010 Oct; 26(7):525-33. PubMed ID: 20718077 [TBL] [Abstract][Full Text] [Related]
10. cAMP signalling in insulin and glucagon secretion. Tengholm A; Gylfe E Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():42-53. PubMed ID: 28466587 [TBL] [Abstract][Full Text] [Related]
16. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells? Whalley NM; Pritchard LE; Smith DM; White A J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304 [TBL] [Abstract][Full Text] [Related]
17. The predominant distribution of vesicular monoamine transporter 2 in the α cells and δ cells, not β cells, in rat islets. Gao Y; Liu L; Li X; Song Y; Zhang Y; Zhu J Pancreas; 2011 Oct; 40(7):1149-51. PubMed ID: 21705944 [No Abstract] [Full Text] [Related]
18. Immunohistochemical study of α- and β-cell distribution in human pancreatic Langerhans islets of various types. Proshchina AE; Savel'yev SV Bull Exp Biol Med; 2013 Oct; 155(6):798-801. PubMed ID: 24288769 [TBL] [Abstract][Full Text] [Related]
19. Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells. Mohan R; Mao Y; Zhang S; Zhang YW; Xu CR; Gradwohl G; Tang X J Biol Chem; 2015 Aug; 290(32):19955-66. PubMed ID: 26109062 [TBL] [Abstract][Full Text] [Related]
20. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion. Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]